Antibody Purification Process
2021-11-27 14:11
Antibody drugs have explosive growth due to their high specificity and affinity for binding to specific targets, as well as the ease of humanization and full humanization of the target protein sequences. In the past 20 years, these products have developed rapidly, with more than 300 monoclonal antibodies currently in clinical trials. Monoclonal antibodies have been approved for widespread use in multiple indications such as malignant tumors, immunological diseases, and rare diseases.
Common antibody purification processes first involve centrifugation and filtration of the reactor harvest fluid to remove cells and cell debris, followed by Protein A chromatography to capture antibodies. After capture, the antibodies undergo low pH viral inactivation, then are purified through two ion exchange chromatography steps, followed by viral filtration. Finally, ultrafiltration and diafiltration are performed to adjust antibody concentration and buffer exchange, resulting in the antibody bulk solution.
Truking's innovative chromatography process replaces the traditional two-step ion exchange chromatography with a one-step mixed-mode chromatography based on the conventional purification process to achieve separation and purification effects.
